Literature DB >> 18829218

C-reactive protein (CRP) elevation in patients with abdominal aortic aneurysm is independent of the most important CRP genetic polymorphism.

Stephen A Badger1, Chee V Soong, Mark E O'Donnell, Caroline Mercer, Ian S Young, Anne E Hughes.   

Abstract

OBJECTIVE: C-reactive protein (CRP) is a marker of cardiovascular disease. The objective was to determine if abdominal aortic aneurysm (AAA) and CRP serum concentration and its CRP gene are associated. METHODS AND
RESULTS: AAA patients and AAA negative controls were recruited. CRP concentration was measured and the single nucleotide polymorphism (SNP), rs3091244, assessed. AAA cases were divided into those measuring 30-55 mm and >55 mm in diameter, to assess correlation of CRP with AAA size. A total of 248 (227 male) cases and 400 (388 male) controls were included. CRP concentration was higher in cases (385.0 microl/dL [310.4-442.8] vs 180.3 microl/dL [168.1-196.9]; P < .0001). It was higher in large aneurysms (685.7 microl/dL [511.8-1083.0] vs 291.0 microl/dL [223.6-349.6]; P < .0001), with significant correlation observed to size (r = 0.37, P < .0001). CC was the most common SNP genotype with no difference in distribution (P = .43) between cases and controls. No difference existed in CRP for each genotype in the overall cohort (P = .17), cases (P = .18) and controls (P = .19).
CONCLUSION: The results demonstrate that CRP production may be related to the presence of AAA, especially in advanced disease. The serum concentration of CRP does not appear to be influenced by the functional SNP of the CRP gene, which also appears to have no association with AAA formation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18829218     DOI: 10.1016/j.jvs.2008.07.081

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  6 in total

1.  Role of complement cascade in abdominal aortic aneurysms.

Authors:  Irene Hinterseher; Robert Erdman; Larry A Donoso; Tamara R Vrabec; Charles M Schworer; John H Lillvis; Amy M Boddy; Kimberly Derr; Alicia Golden; William D Bowen; Zoran Gatalica; Nikos Tapinos; James R Elmore; David P Franklin; John L Gray; Robert P Garvin; Glenn S Gerhard; David J Carey; Gerard Tromp; Helena Kuivaniemi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-04-14       Impact factor: 8.311

2.  Plasma levels of cathepsins L, K, and V and risks of abdominal aortic aneurysms: a randomized population-based study.

Authors:  Bing-Jie Lv; Jes S Lindholt; Jing Wang; Xiang Cheng; Guo-Ping Shi
Journal:  Atherosclerosis       Date:  2013-07-14       Impact factor: 5.162

Review 3.  Genes and abdominal aortic aneurysm.

Authors:  Irene Hinterseher; Gerard Tromp; Helena Kuivaniemi
Journal:  Ann Vasc Surg       Date:  2010-12-13       Impact factor: 1.466

4.  Chlamydia pneumoniae antibodies and C-reactive protein levels in patients with abdominal aortic aneurysms.

Authors:  M A Sharif; D A McDowell; S A Badger
Journal:  ScientificWorldJournal       Date:  2013-12-28

5.  Interleukin-6 Receptor Signaling and Abdominal Aortic Aneurysm Growth Rates.

Authors:  Ellie Paige; Marc Clément; Fabien Lareyre; Michael Sweeting; Juliette Raffort; Céline Grenier; Alison Finigan; James Harrison; James E Peters; Benjamin B Sun; Adam S Butterworth; Seamus C Harrison; Matthew J Bown; Jes S Lindholt; Stephen A Badger; Iftikhar J Kullo; Janet Powell; Paul E Norman; D Julian A Scott; Marc A Bailey; Stefan Rose-John; John Danesh; Daniel F Freitag; Dirk S Paul; Ziad Mallat
Journal:  Circ Genom Precis Med       Date:  2019-02

6.  Fcγ receptor activation mediates vascular inflammation and abdominal aortic aneurysm development.

Authors:  Laura Lopez-Sanz; Susana Bernal; Luna Jimenez-Castilla; Ignacio Prieto; Sara La Manna; Sergio Gomez-Lopez; Luis Miguel Blanco-Colio; Jesus Egido; Jose Luis Martin-Ventura; Carmen Gomez-Guerrero
Journal:  Clin Transl Med       Date:  2021-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.